chrisvoncsefalvay/vaers-outcomes huggingface dataset:
didn't recieve the 2nd part of his shingles vaccine!!; This case was reported by a consumer via interactive digital media and described the occurrence of incomplete course of vaccination in a male patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Previously administered products included Shingles vaccine (1st dose received on an unknown date).   On an unknown date, the patient received the 2nd dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.  Additional details were provided as follows: The reporter was the patient's wife. The age at vaccination was not applicable for this report. The reporter stated that, till the time of reporting, the patient did not receive 2nd dose of Havrix, which led to incomplete course of vaccination. The reporter stated that, her husband got the the first shot and went to get the second one the other day and find out it was not coverd and had a 191.00 price tag needless to say he did not recieve the 2nd part of his shingles vaccine. The reporter consented to follow up.
Fever of 99.3F Body aches Chills Great left arm pain at injection site
Immediately after the vaccination,  my stomach started to hurt and I started to get a panic feeling.  I was in the waiting room, developed hives, started to itch and threw up.  I went home and took 2 Allegra and Pepcid.  I called my doctor to inform him. He instructed to increase my meds to 4 tablets of Allegra daily and 2 Pepcid daily.  At home, my throat started to get scratchy like it was closing up.  I wanted to wait it out.  The next day, I developed a pain in the lower left area of my abdomen and had severe diarrhea.  This was happening on and off for about 2 weeks. I called my doctor to inform him.  Things did start to improve and I had another episode of hives.   I also developed episcleritis which is inflammation in my eye.  I went to an optometrist and was prescribed an eye drop which contained antibiotics and dexamethasone.  That did not help my condition.  I went to Urgent Care and  was instructed to go to the ER (Ohio Health Pickerington).  They examined my eyes and referred me to an opthalmologist.  The next day, I went to the opthalmologist and was diagnosed with episcleritis and prescribed Prednisolone eye drops.  It seems to be helping.  I again developed severe hives on 6/20/2021 from head to knees and prescribed Prednisone.  The prednisone helped clear up my hives as well as the episcleritis.
Fever of over 101 degrees for one week and a half. Loss of taste and smell. Extreme fatigue. Thick mucus. Cough. These began the day of the vaccine and lasted until Wednesday of the following week.
Narrative: About 25 minutes after receiving 2nd dose of Pfizer COVID-19 vaccine, Patient began feeling tingling around the lips/tongue, tightness in her throat, shortness of breath, and lightheadedness. Pt then began complaining of fire-like sensation in while body. Provider called to evaluate and medicated with epinephrine which reduced severity of symptoms. EMS activated and pt sent out via ambulance.
Extremely heavy menstrual cycle. Heaviest I have experienced in my life.  Duration of cycle was not impacted
Pt presented w/vertigo night of vaccination on 3/18 and still w/persistent vertigo x 1 month from vaccine.
first dose of Pfizer-Biontech Covid19 vaccine 10 days ago.  She has since gone for a PCR test for Sars-Cov-2 infection which came back positive.  Could the vaccine have caused a false positive?; This is a spontaneous report received from a contactable consumer. This consumer reported for a female patient (Daughter) who received 1st dose of BNT162B2 (Pfizer-Biontech Covid-19 Vaccine, solution for injection) on 01Feb2021 as a single dose for COVID-19 immunization. Patient's medical history and concomitant medications were not reported. On an unspecified date, Caller's daughter underwent PCR test for SARS-COV-2 infection which results positive, after her first dose of Pfizer-Biontech Covid-19 vaccine 10 days ago. Caller questioned could the vaccine had caused a false positive result. Outcome of the event was unknown.  Information on the Lot/Batch number has been requested.   Follow-up attempts are completed. No further information is expected.
Full body hives for 4 days.  Began in feet and progressed on body.
Pain, rash, itching, and swelling at injection site.   Patient stated that the swollen area kept increasing in size each day with increase severity in itching as well
This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A female patient received bnt162b2 (BNT162B2), administration date 14Feb2021 (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Dose 1, Manufacturer Unknown), for COVID-19 immunisation. The following information was reported: PAIN IN EXTREMITY (non-serious), outcome "unknown", described as "Arm was sore"; SLUGGISHNESS (non-serious), outcome "unknown", described as "Sluggish". Additional Information: The patient reported that other than the side effects, she was fine and also stated the COVID-19 shot was put a little higher. It was reported that the patient was a "CNA" for 19 years at the hospital and once COVID came out, she was pulled out of the hospital because of her lungs. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
DEVELOPED CHILLS AND BODY ACHES EVENING OF VACCINATION. GOT VERY RESTLESS AND PAIN OVER BODY DURING NIGHT. DEVELOPED MUSCLE CRAMPS IN UPPER LEGS, CALF, AND ARMS THAT CONTINUES OFF AND ON. WENT TO THE CARDIOLOGIST FOR CHECK UP BECAUSE SHE DEVELOPED WATER RETENTION AFTER 1ST DOSE OF COVID VACCINE AND STARTED DEVELOPING SAME AFTER 2ND DOSE. CARDIOLOGIST NOTED, SOME FLUID AT THE BOTTOM OF HER LUNGS. SWELLING BEGINNING TO AFFECT LOWER LEGS AGAIN. BEING FOLLOWED BY MEDICAL TEAM.
Patient neglected to tell the nurse administering COVID vaccine that she has fainted in the past. After getting the vaccine she seemed fine and walked over to the observation area. She suddenly stated she felt dizzy to a companion then collapsed onto the floor striking her forehead. She was unconscious briefly and a little dusky around her mouth. She awakened upon stimulation and was evaluated. Her vital signs were reassuring but a growing hematoma on her forehead prompted ac referral to the ED by ambulance. She was seen there and discharged without imaging. She had some fatigue, headache and vertigo for several days.
Received PENTACEL, HEP B, PREVNAR, & ROTAVIRUS 11/26/10 - crying -> difficult to console, swelling at site of injections - advised TYLENOL q6 hours, cool application, soothing measures reviewed.
Hospitalized (2.15.22 - 2.23.22); COVID-19 positive (2.15.22);  fully vaccinated with one dose J&J Discharge Provider: DO Primary Care Provider at Discharge: DO Admission Date: 2/15/2022 Discharge Date: 2/23/2022 DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Physical deconditioning [R53.81] Intertriginous candidiasis [B37.2] COVID [U07.1] COVID-19 [U07.1] COVID-19 with pulmonary comorbidity [U07.1, J98.4] HOSPITAL COURSE: Patient is a 48 y.o. female who presented today with a history of Alpha-1-antitrypsin, GERD, waiting with baseline 3L NC, Cerebral palsy. Patient complainted of shortness of breath and fatigue lasting for 4-5 days, and stated that "it burned when she urinated". Patient has been home for the past week while her fiance has been hospitalized. During the fiances hospitalization, patient was home alone with minimal assistance until he came home on Sunday. Patient had increased difficulty getting out of her chair and unable to bathe self without help. Patient brought into E.D. because fiance feels like he can not support patient at this time. It the E.D. Patient was found to be sitting in stool on her chair. UA collected was negative for UTI. Patient tested positive for Covid-19 in E.D. Labs and CXR done in E.D. are unremarkable. Hospitalist services contacted to admit patient for PT/OT evaluation and care management for possible discharge home with home services.  Chronic conditions of chronic obstructive pulmonary disease, obesity and cerebral palsy with extreme deconditioning hinder the course.  Chronic anxiety and depression  led to promoting increased air trapping on top of chronic condition of chronic obstructive pulmonary disease.  Continue home medications.  Cannot continue aerosolized albuterol treatments r/t facilitation of the spread of COVID.   Increased wheezing ->  change steroids to Solu-Medrol from Decadron. She was continued on 3 L of oxygen via nasal cannula which is her home supplemental oxygen level.  Symptomatic support for COVID-19 included Solu-Medrol, Symbicort, albuterol inhaler, Flonase, Lovenox for DVT and PE prophylaxis as well as supplemental oxygen. Concern for continuing to fail to thrive as an adult.   Discussed patient needs today.  Discussed completing the paperwork she/her fiance started for additional help in the home.  Discussed the need for physical therapy and to continue to move and do as much as she safely can for herself to reduce continued deconditioning.  Recommended discharge location for PT/ OT assessment: home, with assist, with home health, PT  Case management social worker working on contacting the family to ascertain what additional support she has.  She continued to improve and stabilize and was seen on the day of discharge ready to go home.  Care management made arrangements for HHN and chore worker.  She was discharged home on medrol dose pak and to continue her usual medications.  She is at her baseline O2 requirement.  She can return to activity and diet at usual.  She is recommended to follow up with her PCP to ensure resolution of her symptoms.  She understood these instructions and was discharged home in stable condition
vision became blurry on her left side which started 25 mins after receiving the shot, having a real bad headache on left side and has been hurting really bad every day also the pain radiates down her neck and leg cramps
Injection site soreness; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Injection site soreness) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20A) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Feb-2021, the patient experienced VACCINATION SITE PAIN (Injection site soreness). At the time of the report, VACCINATION SITE PAIN (Injection site soreness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter.  Treatment information was not provided.   This case was linked to MOD-2021-047837 (Patient Link).
12 years postmenopausal started spotting this morning-2 days after vaccine; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A 62 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 10Jan2022 10:30 (Lot number: F51611) at the age of 62 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "mild CADm" (unspecified if ongoing); "COPD" (unspecified if ongoing); "Asthma" (unspecified if ongoing); "COVID-19" (unspecified if ongoing). Concomitant medication(s) included: IBUPROFEN. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The following information was reported: POSTMENOPAUSAL HAEMORRHAGE (medically significant) with onset 12Jan2022 07:00, outcome "not recovered", described as "12 years postmenopausal started spotting this morning-2 days after vaccine". Therapeutic measures were not taken as a result of postmenopausal haemorrhage. Since the vaccination, the patient had not been tested for COVID-19.  No follow-up attempts are possible. No further information is expected.
Information has been received from a registered nurse concerning multiple unknown patients of unknown age. The patients' medical histories, concurrent conditions and concomitant therapies were not provided. On multiple unknown dates since "October 2015", the patients were vaccinated with improperly stored ZOSTAVAX (lot#, expiration, dose and route unknown) for prophylaxis. Information regarding temperature excursion of vaccine was unknown. Data logger was involved. No adverse effects were reported. This is one of several reports received from the same source. Additional information has been requested. Sender's Comments: US-009507513-1703USA001265: US-009507513-1702USA011328: US-009507513-1703USA001264.
Patient was well. Recieved RotaTeq #3 on 06/20/11. Developed frequent vomiting on 07/02/11 followed with abdomonial distension and lethargy. Confirmed ileo-colic intussusception and required surgical reduction on 07/05/11.
Sharp pain on the left side of my neck immediately after shot in my left arm.  Within 15 mins the left side of my face and left pinky finger started feeling numb and my left arm was heavy.
Signs/Symptoms: anxiety; auditory disturbance; cold extremities; dizziness; facial pallor; fatigue; feeling of warmth; lightheadedness; hypotensive LOC; restlessness. Description:  After receiving the Rabies vaccine, donor stated he felt dizzy and lost consciousness for more than 60 seconds.  Donor's legs were elevated and he was fanned.  Vitals were taken every 5-15 minutes and were in normal range.  Donor was given water, a protein bar, and PowerAde.  Donor stated he had been nervous about receiving the shot.  Donor left the center in good condition.
testing positive for COVID after receiving vaccine; testing positive for COVID after receiving vaccine; This is a spontaneous report from a contactable pharmacist. This pharmacist reported similar event for 14 patients. This is the 14th of 14 reports. An elderly patient (more than 65 years old) of an unspecified gender received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 13Jan2021 at single dose for covid-19 immunization.  The patient's medical history and concomitant medications were not reported. The patient experienced testing positive for COVID after receiving vaccine on 21Jan2021. It was reported that 8 patients and 6 workers at a long term care facility were vaccinated on 13Jan2021 and reported testing positive for COVID on 21Jan2021. Since they were testing positive, physician wanted to administer bamlanirimab (Lily drug being administered under ). The event resulted in doctor or other healthcare professional office/clinic visit. Outcome of the events was unknown.  Information about lot/batch number has been requested.; Sender's Comments: Based on available information, a possible contributory role of BNT162B2 cannot be excluded for reported "testing positive for COVID after receiving vaccine".,Linked Report(s) : US-PFIZER INC-2021063794 same reporter/drug/event, different patient
Around 11:15, 45 minutes after my injection. I started to feel a little bit weak and dizzy. This gradually got worse and worse, until I lost the ability to see because it was so blurry, and anything bright would cause me an agonizing headache. Later, I started to lose functionality in my legs and arms, I just felt weak. This weakness continued and grew to exhaustion. The feeling ill, weakness, and exhaustion continued for a little bit over 48 hours. And my blurry vision, sensitivity to brightness, and agonizing headache continued for about 72 hours. The worst part about the whole ordeal is that the physiological changes the vaccine did to my body. I typically am not cold, yet I continuously felt cold for about 2 months, not only my weakness and loss of functionality continued for about 2 months as well yet not regular.
Patient given his 2nd Pfizer vaccine 7 days before the recommended time between the 1st and 2nd dose. Patient notified of the vaccine administration error.
Pt had no problems until redness began at vaccine site on the morning of 11/26/01. Initially it was one red spot about 1 cm in diameter, but by the end of the day, there were 5-7 separate red spots close together. By the morning of 11/27, spots had merged into one lesion, red, slightly raised and warm, 5.3 x 2.8 cm. Pt's physical was otherwise nml. No Rx was prescribed at that time.
fast and pounding/fluttering heart beat; Chest pain; heart palpitations; This is a spontaneous report from a contactable consumer (patient). This 49-year-old female patient (non-pregnant at time of vaccination) received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration in the Arm Left on 13Aug2021 (at the age of 49-year-old; lot number: FC3180) as DOSE 1, SINGLE for COVID-19 immunization. Medical history included known allergies of shellfish, asthma and allergies. No covid prior vaccination. No covid tested post vaccination. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Patient did not receive any other medications within 2 weeks of vaccination. There were no concomitant medications. On unspecified date, the patient experienced chest pain, heart palpitations, fast and pounding/fluttering heart beat. The events resulted in Emergency room/department or urgent care. Treatment received for events. Prior to vaccination, the patient did not diagnose with COVID-19. Since the vaccination, has the patient did not test for COVID-19. Outcome of events was unknown.  No follow-up attempts are possible. No further information is expected.
This spontaneous report was received from a nurse via Poison and Drug Center (PDC) refers to a patient of unknown gender between the age of 2 years and 5 years old. The patient's relevant medical history, past drug history and concomitant medications were unknown. On 26-MAY-2015, the single dose vial of PROQUAD (Merck) underwent temperature excursions 5.3 degrees Celsius for 2 hours and 8 minutes, on 07-JUL-2015 underwent temperature excursions 8.9 degree celsius for 1 hour and 28 minutes, on 28-JUL-2015 underwent temperature excursions 0.4 degrees celsius for 1 hour and 25 minutes. On 28-JUL-2015, the patient was vaccinated with improperly stored PROQUAD (Merck) (lot # K020748 and expiration date 30-APR-2016) via injection (dose, frequency and indication were unknown). The patient had not experienced any adverse events. It was unknown if there was any relevant laboratory data. As of 05-AUG-2015, it was unknown if the patient continues on PROQUAD (Merck). This is one of the eight reports received from the same source. Additional information has been requested.
Hoarseness, tightness in chest, wheezing and coughing spells.
I took a PCR Wednesday April 29th and was positive; I took a PCR Wednesday April 29th and was positive; This is spontaneous report received from Pfizer from a contactable consumer (patient). A patient of unknown age and gender received first dose and second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on 28Dec2020 and 16Jan2021 seperately, at single dose for COVID-19 immunization. Medical history and concomitant medications were not reported. The patient received covid vaccine 28Dec2020 and 16Jan2021. The patient had a bad reaction after the second dose but was fine 24 hours later. The patient recently traveled, took a PCR Wednesday 29Apr2021 and was positive. The patient was assuming he/she had a variant strain of the virus, which was unfortunately not able to be covered by the vaccine but just wanted to let you know in case you want a research subject. The outcome of the events was unknown.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Child received immunization of Varicella on 12/13/2006.  Grandma reported that he developed a blister at site of immunization. States it is all dried up now. Also stated he had a rash over his body, but could not tell me what type or when. She states it is gone now. Date she called was 01/05/07.
This case was reported by a consumer via call center representative and described the occurrence of injection site erythema in a 80-year-old female patient who received SHINGRIX (batch number D294J, expiry date 22nd March 2021) for prophylaxis. On 2nd November 2018, the patient received the 1st dose of SHINGRIX. In November 2018, less than a week after receiving SHINGRIX, the patient experienced injection site erythema and injection site warmth. On an unknown date, the patient experienced incorrect storage of drug. On an unknown date, the outcome of the injection site erythema, injection site warmth and incorrect storage of drug were unknown. It was unknown if the reporter considered the injection site erythema and injection site warmth to be related to SHINGRIX. Additional details were provided as follows: The patient reported that she was able to locate her dose of SHINGRIX at a pharmacy that did not actually give the vaccines. The patient noted it was a hospital pharmacy. The patient did not know the vaccine needed to be refrigerated, and it was out of recommended storage for about a week, which led to incorrect storage of drug. The patient took it to her physician office and the nurse there gave her the vaccination on left arm. The patient stated that, she had a 3 inch circular pale red area of warmth at the injection site.
Arm got a little sore; swollen; hot to touch; Itcyy; red wheeled; This spontaneous case was reported by an other health care professional and describes the occurrence of PAIN IN EXTREMITY (Arm got a little sore), VACCINATION SITE ERYTHEMA (red wheeled), PERIPHERAL SWELLING (swollen), INFLAMMATION (hot to touch) and PRURITUS (Itcyy) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Arm got a little sore), VACCINATION SITE ERYTHEMA (red wheeled), PERIPHERAL SWELLING (swollen), INFLAMMATION (hot to touch) and PRURITUS (Itcyy). The patient was treated with STEROIDS for Adverse event, at a dose of UNK dosage form. At the time of the report, PAIN IN EXTREMITY (Arm got a little sore), VACCINATION SITE ERYTHEMA (red wheeled), PERIPHERAL SWELLING (swollen), INFLAMMATION (hot to touch) and PRURITUS (Itcyy) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
soreness, swelling and discoloring at site of injection, redness just below site of injection, headache, fever, body aches, sore throat
about 3 minutes after vaccinations given, client moaned, then fainted on the exam table. She closed her eyes for a few seconds and then woke up. cool pack applied to forehead and knees elevated while laying supine on exam table.  She was feeling better then, sat up, and fainted again. Cool pack applied again, knees elevated. Mom had some juice, so client drank some of that. Layed supine for about 15 minutes and then felt better. Assisted to walk home after.